Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line

Sponsor

Imam Abdulrahman Bin Faisal University (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05543772

Collaborator

(none)

150

Enrollment

Arm

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Background: Peripheral Intravenous catheter (PIVC) is a frequently used device for intravascular access. It is usually indicated to administer intravenous fluid and medications. However, the investigators could possibly utilize this line for blood sampling even after using it as a fluid port.

Condition or Disease	Intervention/Treatment	Phase
Emergencies	Drug: Normal saline	Phase 4

Detailed Description

Aims: To investigate the quality of previously flushed PIVC sample and the effectiveness of the withdrawal technique.

Methodology: Study will be held in King Fahad University Hospital during a year after obtaining the IRB approval. Selection of study participants will be depending on their health status and the investigators will exclude pediatric participants. Two blood samples will be collected from participants. First one is after the insertion of the intravenous peripheral line. The second is after fluid infusion through the same line. Samples will be sent to the laboratory then. Results will be collected and analyzed.

The importance of the research: If this type of sampling can be standardized , this means there will be less insertions to the patients, less adverse effects in relation to the number of insertions, fast and preexisted intravascular access for sampling so the time can be saved in critical conditions.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

150 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Diagnostic

Official Title:

Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line (Indwelling Line): a Technique to Keep Optimal Specimen After Fluid Flush

Anticipated Study Start Date :

Sep 30, 2022

Anticipated Primary Completion Date :

May 1, 2023

Anticipated Study Completion Date :

May 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Normal saline Study will be held in King Fahad University Hospital during a year after obtaining the IRB approval. Selection of study participants will be depending on their health status and the investigators will exclude pediatric participants. Two blood samples will be collected from participants. First one is after the insertion of the intravenous peripheral line. The second is after fluid infusion through the same line. Samples will be sent to the laboratory then. Results will be collected and analyzed.	Drug: Normal saline participant will be given 500 ml normal saline through intravenous access. blood sample will be extracted before and after giving normal saline using same intravenous catheter

Arm

Intervention/Treatment

Experimental: Normal saline

Study will be held in King Fahad University Hospital during a year after obtaining the IRB approval. Selection of study participants will be depending on their health status and the investigators will exclude pediatric participants. Two blood samples will be collected from participants. First one is after the insertion of the intravenous peripheral line. The second is after fluid infusion through the same line. Samples will be sent to the laboratory then. Results will be collected and analyzed.

Drug: Normal saline

participant will be given 500 ml normal saline through intravenous access. blood sample will be extracted before and after giving normal saline using same intravenous catheter

Outcome Measures

Primary Outcome Measures

Paired ttest [1 year]
Paired ttest to detect if there is any significant differences in blood gas results before and after intervention (normal saline), where the same individuals are measured before and after the intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

It will include healthy adult volunteers.

Exclusion Criteria:

Pediatric patients and critically ill patients will be excluded from the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Imam Abdulrahman Bin Faisal University

Investigators

Principal Investigator: Dunya N Alfaraj, MD, Imam Abdulrahman Bin Faisal University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Dunya N Alfaraj, MD, Emergency Consultant, Imam Abdulrahman Bin Faisal University

ClinicalTrials.gov Identifier:

NCT05543772

Other Study ID Numbers:

IABFUniversity

First Posted:

Sep 16, 2022

Last Update Posted:

Sep 16, 2022

Last Verified:

Sep 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Product Manufactured in and Exported from the U.S.:

Additional relevant MeSH terms:

Emergencies

Study Results

No Results Posted as of Sep 16, 2022